ロード中...
Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter
Cisplatin is one of the most potent chemotherapeutic agents for the treatment of colon cancer. Nevertheless, the unavoidability of the notable toxicity and the development of the acquired resistance severely restricted its clinical application. Aspirin and some other non-steroidal anti-inflammatory...
保存先:
| 出版年: | Aging (Albany NY) |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6977689/ https://ncbi.nlm.nih.gov/pubmed/31905343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.102644 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|